Offer - Urjas Oil for just ₹ 1 X
Emtri 150/40/200 Tablet (30) is a prescription drug, available for use as Tablet. The alternative uses of Emtri 150/40/200 Tablet (30) have also been explained below.
The optimal dosage of Emtri 150/40/200 Tablet (30) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Emtri 150/40/200 Tablet (30) side effects, there are can be others also. These have been listed below. These side effects of Emtri 150/40/200 Tablet (30) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Emtri 150/40/200 Tablet (30)'s effect during pregnancy is Moderate and Mild while nursing. Warnings related to Emtri 150/40/200 Tablet (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Emtri 150/40/200 Tablet (30) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emtri 150/40/200 Tablet (30) in conditions like Kidney Disease, Pancreatitis, Liver Disease. Other conditions have been mentioned below in the Emtri 150/40/200 Tablet (30) contraindications section.
Drug interactions for Emtri 150/40/200 Tablet (30) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Emtri 150/40/200 Tablet (30) is not safe while driving, and is is not addictive in nature.
Emtri 150/40/200 Tablet (30) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Emtri 150/40/200 Tablet (30) safe for pregnant women?
Pregnant women may experience moderate side effects from Emtri. It is best to stop taking Emtri immediately and inform your doctor if you notice any discomfort.
Is the use of Emtri 150/40/200 Tablet (30) safe during breastfeeding?
Breastfeeding women can take Emtri as it bears very minor side effects for them.
What is the effect of Emtri 150/40/200 Tablet (30) on the Kidneys?
Emtri may have mild side effects on the kidneys.
What is the effect of Emtri 150/40/200 Tablet (30) on the Liver?
Emtri has very mild side effects on the liver.
What is the effect of Emtri 150/40/200 Tablet (30) on the Heart?
Using Emtri does not have any harmful effects on the heart.
Emtri 150/40/200 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Emtri 150/40/200 Tablet (30) unless your doctor advises you to do so -
Is this Emtri 150/40/200 Tablet (30) habit forming or addictive?
No, you will not get addicted to Emtri 150/40/200 Tablet (30).
Interaction between Food and Emtri 150/40/200 Tablet (30)
Some foods when eaten with Emtri 150/40/200 Tablet (30) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Emtri 150/40/200 Tablet (30)
Consuming Emtri 150/40/200 Tablet (30) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viramune® (nevirapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807